Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer

NCT00537095 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: Vandetanib
OTHER: Placebo

Sponsor

Genzyme, a Sanofi Company